$GNTX
GENTEX CORP Stock $gntx

$gntx Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000035581122000022 Filed on May 05, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$468.3M	$483.7M
YoY Change	-3.2%	6.6%
Cost Of Revenue	$307.8M	$300.4M
YoY Change	2.47%	1.09%
Gross Profit	$160.4M	$183.3M
YoY Change	-12.49%	17.06%
Gross Profit Margin	34.26%	37.89%
Selling, General & Admin	$25.13M	$21.91M
YoY Change	14.68%	-0.14%
% of Gross Profit	15.67%	11.96%
Research & Development	$31.97M	$27.65M
YoY Change	15.63%	-6.63%
% of Gross Profit	19.93%	15.09%
Depreciation & Amortization	$24.71M	$25.60M
YoY Change	-3.47%	-2.65%
% of Gross Profit	15.41%	13.97%
Operating Expenses	$57.11M	$49.57M
YoY Change	15.21%	-3.87%
Operating Profit	$103.3M	$133.7M
YoY Change	-22.75%	27.33%
Interest Expense	$788.3K	$1.000M
YoY Change	-21.17%	-56.52%
% of Operating Profit	0.76%	0.75%
Other Income/Expense, Net	-$10.49K	$1.533M
YoY Change	-100.68%	-31.79%
Pretax Income	$103.3M	$135.3M
YoY Change	-23.64%	26.09%
Income Tax	$15.77M	$21.82M
% Of Pretax Income	15.26%	16.13%
Net Earnings	$87.53M	$113.5M
YoY Change	-22.85%	26.75%
Net Earnings / Revenue	18.69%	23.45%
Basic Earnings Per Share	$0.37	$0.47
Diluted Earnings Per Share	$0.37	$0.46
COMMON SHARES
Basic Shares Outstanding	232.2M shares	239.6M shares
Diluted Shares Outstanding	232.8M shares	241.7M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$286.6M	$481.9M
YoY Change	-40.53%	17.65%
Cash & Equivalents	$279.7M	$455.9M
Short-Term Investments	$6.892M	$25.90M
Other Short-Term Assets	$24.73M	$17.90M
YoY Change	38.17%	8.48%
Inventory	$362.7M	$233.1M
Prepaid Expenses
Receivables	$281.5M	$277.7M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$955.5M	$1.011B
YoY Change	-5.44%	10.96%
LONG-TERM ASSETS
Property, Plant & Equipment	$468.4M	$460.6M
YoY Change	1.7%	-6.6%
Goodwill	$313.9M	$314.7M
YoY Change	-0.25%	0.01%
Intangibles	$234.2M	$256.9M
YoY Change	-8.83%	4.63%
Long-Term Investments	$175.8M	$172.9M
YoY Change	1.69%	-2.76%
Other Assets	$756.4M	$771.3M
YoY Change	-1.93%	2.26%
Total Long-Term Assets	$1.225B	$1.232B
YoY Change	-0.57%	-1.24%
TOTAL ASSETS
Total Short-Term Assets	$955.5M	$1.011B
Total Long-Term Assets	$1.225B	$1.232B
Total Assets	$2.180B	$2.242B
YoY Change	-2.77%	3.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$140.9M	$107.1M
YoY Change	31.59%	6.96%
Accrued Expenses	$98.34M	$116.2M
YoY Change	-15.35%	30.73%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due		$0.00
YoY Change		-100.0%
Total Short-Term Liabilities	$239.2M	$223.2M
YoY Change	7.16%	-15.43%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$12.19M	$18.06M
YoY Change	-32.5%	98.65%
Total Long-Term Liabilities	$12.19M	$18.06M
YoY Change	-32.5%	98.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$239.2M	$223.2M
Total Long-Term Liabilities	$12.19M	$18.06M
Total Liabilities	$251.4M	$281.5M
YoY Change	-10.68%	-12.99%
SHAREHOLDERS EQUITY
Retained Earnings	$1.039B	$1.085B
YoY Change	-4.29%	6.57%
Common Stock	$895.4M	$873.8M
YoY Change	2.47%	7.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.929B	$1.961B
YoY Change
Total Liabilities & Shareholders Equity	$2.180B	$2.242B
YoY Change	-2.77%	3.91%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	$87.53M	$113.5M
YoY Change	-22.85%	26.75%
Depreciation, Depletion And Amortization	$24.71M	$25.60M
YoY Change	-3.47%	-2.65%
Cash From Operating Activities	$116.0M	$190.8M
YoY Change	-39.24%	26.16%
INVESTING ACTIVITIES
Capital Expenditures	-$24.35M	-$14.20M
YoY Change	71.46%	-21.55%
Acquisitions	$0.00	$12.02M
YoY Change	-100.0%
Other Investing Activities	$22.30M	-$26.40M
YoY Change	-184.48%	3.13%
Cash From Investing Activities	-$2.044M	-$40.61M
YoY Change	-94.97%	-7.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$67.93M	$88.43M
YoY Change	-23.18%	-48.43%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$96.52M	-$117.7M
YoY Change	-17.98%	-6.14%
NET CHANGE
Cash From Operating Activities	$116.0M	$190.8M
Cash From Investing Activities	-$2.044M	-$40.61M
Cash From Financing Activities	-$96.52M	-$117.7M
Net Change In Cash	$17.40M	$32.57M
YoY Change	-46.59%	-283.01%
FREE CASH FLOW
Cash From Operating Activities	$116.0M	$190.8M
Capital Expenditures	-$24.35M	-$14.20M
Free Cash Flow	$140.3M	$205.0M
YoY Change	-31.57%	21.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000355811
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	0-10235
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	GENTEX CORPORATION
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MI
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	38-2030505
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	600 N. Centennial
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Zeeland
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MI
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	49464
CY2022Q1	dei	City Area Code CityAreaCode	616
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	772-1800
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.06 per share
CY2022Q1	dei	Trading Symbol TradingSymbol	GNTX
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	234459296	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	279708413	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	262311670	USD
CY2022Q1	us-gaap	Short Term Investments ShortTermInvestments	6891621	USD
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	5423612	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	281461678	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	249794906	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	362736521	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	316267442	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	24733040	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	39178119	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	955531273	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	872975749	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	468409064	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	464121676	USD
CY2022Q1	us-gaap	Goodwill Goodwill	313928914	USD
CY2021Q4	us-gaap	Goodwill Goodwill	313960209	USD
CY2022Q1	us-gaap	Long Term Investments LongTermInvestments	175824026	USD
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	207693147	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	234229803	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	239189627	USD
CY2022Q1	gntx	Patent And Other Assets Net PatentAndOtherAssetsNet	32459405	USD
CY2021Q4	gntx	Patent And Other Assets Net PatentAndOtherAssetsNet	33450758	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	756442148	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	794293741	USD
CY2022Q1	us-gaap	Assets Assets	2180382485	USD
CY2021Q4	us-gaap	Assets Assets	2131391166	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	140887194	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	98342928	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	98335978	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	83313172	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	239223172	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	181656100	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12190413	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	11746599	USD
CY2022Q1	us-gaap	Liabilities Liabilities	251413585	USD
CY2021Q4	us-gaap	Liabilities Liabilities	193402699	USD
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	14068640	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	14186450	USD
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	881371438	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	879413385	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1038656230	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1042461388	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5127408	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1927244	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1928968900	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1937988467	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2180382485	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2131391166	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	468250776	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	483724839	USD
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	307838816	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	300424671	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	160411960	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	183300168	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31974987	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	27652081	USD
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	25131068	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	21914386	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	57106055	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	49566467	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	103305905	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	133733701	USD
CY2022Q1	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	788316	USD
CY2021Q1	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	1023410	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-798810	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	509625	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10494	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1533035	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	103295411	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	135266736	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15766785	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21815866	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	87528626	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	113450870	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.37
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.47
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.37
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.46
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.120
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.120
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	87528626	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	113450870	USD
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-896420	USD
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-852412	USD
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-7795230	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-5118953	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-8691650	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-5971365	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-1636998	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-1074980	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-7054652	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4896385	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	80473974	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	108554485	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1937988467	USD
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3324147	USD
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	71252022	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6788337	USD
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.12
CY2022Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	28354003	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	87528626	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-7054652	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1928968900	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	1963943128	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9265840	USD
CY2021Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	97692763	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5894645	USD
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.12
CY2021Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	28984621	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	113450870	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4896385	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	1960980714	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	87528626	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	113450870	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	24711500	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	25599131	USD
CY2022Q1	gntx	Gain On Disposal Of Assets GainOnDisposalOfAssets	33982	USD
CY2021Q1	gntx	Gain On Disposal Of Assets GainOnDisposalOfAssets	2391	USD
CY2022Q1	gntx	Loss On Disposition Of Assets LossOnDispositionOfAssets	11067	USD
CY2021Q1	gntx	Loss On Disposition Of Assets LossOnDispositionOfAssets	131490	USD
CY2022Q1	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	367879	USD
CY2021Q1	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	486433	USD
CY2022Q1	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	704214	USD
CY2021Q1	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	41681	USD
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1544501	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6788337	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5894645	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	31666772	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7253692	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	46469079	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6768464	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-16082077	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-768229	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	42968193	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	22277513	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	15702241	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	24233539	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	115958543	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	190849001	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	37158611	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	15019323	USD
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	1000000	USD
CY2021Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	2000000	USD
CY2022Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	15889063	USD
CY2021Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	31379609	USD
CY2022Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	23892169	USD
CY2021Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	12599388	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	33740	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	17744	USD
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2021Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	12023440	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	455419	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1643884	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2044300	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5600000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-40609254	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3324147	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9265840	USD
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	28589625	USD
CY2021Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	29243108	USD
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	71252022	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	97692763	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-96517500	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-117670032	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17396743	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	32569715	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	262311670	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	423371036	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	279708413	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	455940751	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	22000000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	313900000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	314000000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	313960209	USD
CY2022Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2022Q1	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	0	USD
CY2022Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2022Q1	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	-31295	USD
CY2022Q1	us-gaap	Goodwill Goodwill	313928914	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5500000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	20000000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	16000000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	12000000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	12000000	USD
CY2022Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	18600000	USD
CY2021Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	16800000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	279708413	USD
CY2022Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	443864742	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	262311670	USD
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	458610950	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	170677313	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	284003	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	6804987	USD
CY2022Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	164156329	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	195025034	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	3093114	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1818868	USD
CY2021Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	196299280	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	5817906	USD
CY2022Q1	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	135887611	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	987081	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	10371045	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	6804987	USD
CY2022Q1	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue	146258656	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1244053	USD
CY2021Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	94417123	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	574815	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	6875230	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	1818868	USD
CY2021Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue	101292353	USD
CY2022Q1	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2022Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	260985427	USD
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	235014277	USD
CY2022Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	37592293	USD
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	34032164	USD
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	64158801	USD
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	47221001	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	362736521	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	316267442	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	87528626	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	113450870	USD
CY2022Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	1360047	USD
CY2021Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	1671188	USD
CY2022Q1	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	86168579	USD
CY2021Q1	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	111779682	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	232151296	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	239559370	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.37
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.47
CY2022Q1	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	86168579	USD
CY2021Q1	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	111779682	USD
CY2022Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	2500	USD
CY2021Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	10883	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	86171079	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	111790565	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	232151296	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	239559370	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	638515	shares
CY2021Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2133781	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	232789811	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	241693151	shares
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.37
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.46
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1572223	shares
CY2022Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	500000	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	271383	shares
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6788337	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5894645	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0180
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0190
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.2816
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.2785
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0242
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0092
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y1M24D
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y1M20D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.38
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.85
CY2022Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	2400000	shares
CY2022Q1	gntx	Net Increase Decrease In Common Stock Shares From Shares Issued In Share Based Compensation And Shares Repurchased NetIncreaseDecreaseInCommonStockSharesFromSharesIssuedInShareBasedCompensationAndSharesRepurchased	-2000000	shares
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.12
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.12
CY2022Q1	us-gaap	Dividends Dividends	28100000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	468250776	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	483724839	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	103305905	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	133733701	USD
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.153
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.161
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	468250776	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	483724839	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.031
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1013318	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	921600	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	159826	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	7102	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	430	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2102276	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	25959	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2076317	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1300709	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	775608	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2076317	USD

Files In Submission

Name	View Source	Status
0000355811-22-000022-index-headers.html	Edgar Link	pending
0000355811-22-000022-index.html	Edgar Link	pending
0000355811-22-000022.txt	Edgar Link	pending
0000355811-22-000022-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
gntx-20220331.htm	Edgar Link	pending
gntx-20220331.xsd	Edgar Link	pending
gntx-20220331_cal.xml	Edgar Link	unprocessable
gntx-20220331_def.xml	Edgar Link	unprocessable
gntx-20220331_htm.xml	Edgar Link	completed
gntx-20220331_lab.xml	Edgar Link	unprocessable
gntx-20220331_pre.xml	Edgar Link	unprocessable
gntx10q03312022-exx311.htm	Edgar Link	pending
gntx10q03312022-exx312.htm	Edgar Link	pending
gntx10q03312022-exx32.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GNTX
GENTEX CORP Stock $gntx

2022 Q1 Form 10-Q Financial Statement

#000035581122000022 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GNTX GENTEX CORP Stock $gntx

2022 Q1 Form 10-Q Financial Statement

#000035581122000022 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GNTX
GENTEX CORP Stock $gntx